Atrás
Rango del Día
$8.80
$9.24
Rango de 52 Semanas
$4.16
$10.94
Volumen
1,931,578
Promedio 50D / 200D
$8.02
/
$6.14
Cierre Anterior
$9.10
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -3.2 | 0.4 |
| P/B | 1.9 | 2.9 |
| ROE % | -45.7 | 3.8 |
| Net Margin % | -638.9 | 3.9 |
| Rev Growth 5Y % | -50.0 | 10.0 |
| D/E | 0.2 | 0.2 |
Puntos Clave
Revenue declined -49.98% annually over 5 years
Debt/Equity of 0.24 — conservative balance sheet
Negative free cash flow of -396.61M
PEG of 0.11 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 42.37%
Capital efficient — spends only 7.05% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-49.98%
Revenue (1Y)-7.61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-45.73%
ROIC-36.86%
Net Margin-638.87%
Op. Margin-682.68%
Seguridad
Debt / Equity
0.24
Current Ratio5.54
Interest Coverage0.00
Valoración
P/E Ratio
-3.23
P/B Ratio1.85
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -7.61% | Revenue Growth (3Y) | -10.81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -49.98% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 68.56M | Net Income (TTM) | -437.99M |
| ROE | -45.73% | ROA | -43.68% |
| Gross Margin | 82.92% | Operating Margin | -682.68% |
| Net Margin | -638.87% | Free Cash Flow (TTM) | -396.61M |
| ROIC | -36.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.24 | Current Ratio | 5.54 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.23 | P/B Ratio | 1.85 |
| P/S Ratio | 20.61 | PEG Ratio | 0.11 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.41B | Enterprise Value | 1.37B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 68.56M | 74.21M | 86.18M | 1.62B | 1.10B |
| Net Income | -437.99M | -521.96M | -615.06M | 515.84M | 528.58M |
| EPS (Diluted) | -3.16 | -3.83 | -4.59 | 3.83 | 3.96 |
| Gross Profit | 56.85M | -404.44M | -486.65M | 994.83M | 581.54M |
| Operating Income | -468.02M | -587.17M | -684.31M | 833.07M | 420.75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.00B | 1.40B | 1.92B | 2.80B | 1.95B |
| Total Liabilities | 237.55M | 248.43M | 328.82M | 724.13M | 522.42M |
| Shareholders' Equity | 765.28M | 1.15B | 1.59B | 2.08B | 1.43B |
| Total Debt | 186.91M | 97.89M | 124.54M | 127.97M | 137.49M |
| Cash & Equivalents | 234.11M | 222.95M | 241.58M | 848.63M | 347.82M |
| Current Assets | 514.08M | 1.04B | 1.59B | 2.52B | 1.56B |
| Current Liabilities | 92.82M | 119.66M | 175.41M | 511.03M | 341.24M |